Cargando…
Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study
BACKGROUND: Mailed fecal immunochemical test (FIT) outreach effectively increases colorectal cancer (CRC) screening but is underutilized. This pilot aimed to determine the use of FIT for CRC screening among Medicare Advantage enrollees when offered via mailed outreach and the factors associated with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485154/ https://www.ncbi.nlm.nih.gov/pubmed/32952612 http://dx.doi.org/10.1177/1756284820945388 |
_version_ | 1783581099193008128 |
---|---|
author | Issaka, Rachel B. Akinsoto, Nkem O. Strait, Erica Chaudhari, Van Flum, David R. Inadomi, John M. |
author_facet | Issaka, Rachel B. Akinsoto, Nkem O. Strait, Erica Chaudhari, Van Flum, David R. Inadomi, John M. |
author_sort | Issaka, Rachel B. |
collection | PubMed |
description | BACKGROUND: Mailed fecal immunochemical test (FIT) outreach effectively increases colorectal cancer (CRC) screening but is underutilized. This pilot aimed to determine the use of FIT for CRC screening among Medicare Advantage enrollees when offered via mailed outreach and the factors associated with FIT return. METHODS: Our pilot study included Medicare Advantage enrollees who were 50–75-years old, not up to date with CRC screening, and had a billable primary care encounter in the prior 3 years. Eligible patients received a letter containing information about CRC screening and a FIT kit, screening status by FIT was then assessed using the electronic health record. RESULTS: Of the 1142 patients identified, 945 were eligible for outreach. On 12-month follow up, 29% of patients (n = 276) completed CRC screening via FIT, with a median return time of 140 days [interquartile range (IQR) 52–257]; 6% (n = 17) of the completed tests were positive, and 53% (n = 9) of patients have completed a diagnostic colonoscopy. Patients with primary encounter <12 months prior to mailed outreach were most likely to complete a FIT. Over the 12-month study period, CRC screening rates increased by 5% (63–68%). CONCLUSIONS: Mailed FIT outreach in a Medicare Advantage population was feasible and led to a 5% increase in CRC screening completion. Our pilot revealed rare incorrect patient addresses and high lab discard rate; both important factors that were addressed prior to larger-scale implementation of a mailed FIT program. Further research is needed to understand the potential impact of multilevel interventions on CRC screening in this healthcare system. |
format | Online Article Text |
id | pubmed-7485154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74851542020-09-17 Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study Issaka, Rachel B. Akinsoto, Nkem O. Strait, Erica Chaudhari, Van Flum, David R. Inadomi, John M. Therap Adv Gastroenterol Clinical Research Study BACKGROUND: Mailed fecal immunochemical test (FIT) outreach effectively increases colorectal cancer (CRC) screening but is underutilized. This pilot aimed to determine the use of FIT for CRC screening among Medicare Advantage enrollees when offered via mailed outreach and the factors associated with FIT return. METHODS: Our pilot study included Medicare Advantage enrollees who were 50–75-years old, not up to date with CRC screening, and had a billable primary care encounter in the prior 3 years. Eligible patients received a letter containing information about CRC screening and a FIT kit, screening status by FIT was then assessed using the electronic health record. RESULTS: Of the 1142 patients identified, 945 were eligible for outreach. On 12-month follow up, 29% of patients (n = 276) completed CRC screening via FIT, with a median return time of 140 days [interquartile range (IQR) 52–257]; 6% (n = 17) of the completed tests were positive, and 53% (n = 9) of patients have completed a diagnostic colonoscopy. Patients with primary encounter <12 months prior to mailed outreach were most likely to complete a FIT. Over the 12-month study period, CRC screening rates increased by 5% (63–68%). CONCLUSIONS: Mailed FIT outreach in a Medicare Advantage population was feasible and led to a 5% increase in CRC screening completion. Our pilot revealed rare incorrect patient addresses and high lab discard rate; both important factors that were addressed prior to larger-scale implementation of a mailed FIT program. Further research is needed to understand the potential impact of multilevel interventions on CRC screening in this healthcare system. SAGE Publications 2020-09-09 /pmc/articles/PMC7485154/ /pubmed/32952612 http://dx.doi.org/10.1177/1756284820945388 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Research Study Issaka, Rachel B. Akinsoto, Nkem O. Strait, Erica Chaudhari, Van Flum, David R. Inadomi, John M. Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study |
title | Effectiveness of a mailed fecal immunochemical test outreach: a
Medicare Advantage pilot study |
title_full | Effectiveness of a mailed fecal immunochemical test outreach: a
Medicare Advantage pilot study |
title_fullStr | Effectiveness of a mailed fecal immunochemical test outreach: a
Medicare Advantage pilot study |
title_full_unstemmed | Effectiveness of a mailed fecal immunochemical test outreach: a
Medicare Advantage pilot study |
title_short | Effectiveness of a mailed fecal immunochemical test outreach: a
Medicare Advantage pilot study |
title_sort | effectiveness of a mailed fecal immunochemical test outreach: a
medicare advantage pilot study |
topic | Clinical Research Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485154/ https://www.ncbi.nlm.nih.gov/pubmed/32952612 http://dx.doi.org/10.1177/1756284820945388 |
work_keys_str_mv | AT issakarachelb effectivenessofamailedfecalimmunochemicaltestoutreachamedicareadvantagepilotstudy AT akinsotonkemo effectivenessofamailedfecalimmunochemicaltestoutreachamedicareadvantagepilotstudy AT straiterica effectivenessofamailedfecalimmunochemicaltestoutreachamedicareadvantagepilotstudy AT chaudharivan effectivenessofamailedfecalimmunochemicaltestoutreachamedicareadvantagepilotstudy AT flumdavidr effectivenessofamailedfecalimmunochemicaltestoutreachamedicareadvantagepilotstudy AT inadomijohnm effectivenessofamailedfecalimmunochemicaltestoutreachamedicareadvantagepilotstudy |